Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth-Ann Roman

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Clinical Journal of Oncology Nursing|September 29, 2011
Immunotherapy for advanced melanomaRuth-Ann Roman
Cancer Immunity|January 8, 2010
Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapyJianda Yuan, David B Page, Geoffrey Y Ku, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2010
Immunologic response to xenogeneic gp100 DNA in melanoma patients: comparison of particle-mediated epidermal delivery with intramuscular injectionBrian A Ginsberg, Humilidad F Gallardo, Teresa S Rasalan, et al.
JAMA|June 7, 2011
KIT as a therapeutic target in metastatic melanomaRichard D Carvajal, Cristina R Antonescu, Jedd D Wolchok, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2008
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefitJianda Yuan, Sacha Gnjatic, Hao Li, et al.
The New England Journal of Medicine|March 9, 2012
Immunologic correlates of the abscopal effect in a patient with melanomaMichael A Postow, Margaret K Callahan, Christopher A Barker, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Clinical Journal of Oncology Nursing|September 29, 2011
Immunotherapy for advanced melanomaRuth-Ann Roman
Cancer Immunity|January 8, 2010
Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapyJianda Yuan, David B Page, Geoffrey Y Ku, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2010
Immunologic response to xenogeneic gp100 DNA in melanoma patients: comparison of particle-mediated epidermal delivery with intramuscular injectionBrian A Ginsberg, Humilidad F Gallardo, Teresa S Rasalan, et al.
JAMA|June 7, 2011
KIT as a therapeutic target in metastatic melanomaRichard D Carvajal, Cristina R Antonescu, Jedd D Wolchok, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2008
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefitJianda Yuan, Sacha Gnjatic, Hao Li, et al.
The New England Journal of Medicine|March 9, 2012
Immunologic correlates of the abscopal effect in a patient with melanomaMichael A Postow, Margaret K Callahan, Christopher A Barker, et al.
Pageof 1